Biosimilars Asia is an on-line event that provides an overview of the interest facts and exhibitors/visitors of the cell and gene therapies industry in China. With the government's support, China is rapidly increasing its production capacity of robust therapies and driving the next wave of innovation, precision manufacturing, and tailored therapies. As part of the 6th Biopharma Development Week, Biosimilars Asia is part of the 2nd Cell and Gene Therapy Manufacturing summit, which will spotlight current regulations, commercialisation, clinical trials market, pricing, and global standards.

This event is ideal for those looking to gain insight into the cell and gene therapies industry in China, as well as those who are looking to benchmark global standards. Exhibitors will have the opportunity to showcase their products and services to a wide audience, while visitors will have the chance to explore the latest developments in the field.

Don't miss the chance to be part of this unique event and gain valuable insights into the cell and gene therapies industry in China. Register now to secure your place at Biosimilars Asia.